Clinical Trial: Interstitial Lung Diseases in the Veterans Administration
Study Status: Active, not recruiting
Recruit Status: Active, not recruiting
Study Type: Observational
Official Title: Interstitial Lung Diseases in the Veterans Administration Health System - A Retrospective Description of Patient Characteristics, Management, and Outcomes
Brief Summary: The primary objective of this research project is to describe the characteristics, diagnosis, management, and outcomes of patients with Interstitial Lung Disease (ILD) who received care at the Veteran's Administration Veterans Integrated Service Network (VISN) 6 Mid-Atlantic Health Care Network (VISN6) (includes North Carolina, Virginia and West Virginia) for up to 5 years.
Detailed Summary:
Sponsor: Robert Tighe
Current Primary Outcome:
- Prevalence of Interstitial Lung Disease in the VISN6 Veterans Administration Patient Population [ Time Frame: up to 5 years ]
- Prevalence of Idiopathic Pulmonary Fibrosis in the VISN6 Veterans Administration Patient Population [ Time Frame: up to 5 years ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
- Accuracy of ICD-9 Codes for diagnosis of Interstitial Lung Disease [ Time Frame: up to 5 years ]Will compare the reported ICD-9 code diagnosis with the diagnosis made after chart review and re-interpretation of the lung imaging and pathology
- Frequency of ICD-9 code diagnosis of Interstitial Lung Disease and clinic consultation with a pulmonary provider [ Time Frame: up to 5 years ]
- Prevalence of Co-morbid Diabetes Mellitus with Interstitial Lung Disease [ Time Frame: up to five years ]Compare the prevalence of diabetes with interstitial lung disease as compared to the prevalence of diabetes in the general VA population
Original Secondary Outcome: Same as current
Information By: Durham VA Medical Center
Dates:
Date Received: June 19, 2015
Date Started: July 2016
Date Completion: June 2017
Last Updated: August 1, 2016
Last Verified: August 2016
